ロード中...
A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®(MMX®)) for active, mild-to-moderate ulcerative colitis
BACKGROUND: Cortiment®(MMX®) (budesonide MMX®) is currently approved for the induction of remission in mild-to-moderate ulcerative colitis (UC) patients when 5-ASA treatment is not sufficient. Data in real-life settings are lacking. METHODS: This was a multicentre observational prospective cohort st...
保存先:
| 出版年: | United European Gastroenterol J |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6826527/ https://ncbi.nlm.nih.gov/pubmed/31700630 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640619864848 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|